Abstract:Abstract Background Drug repurposing has gained increased attention because it proposes to find effective cures for new diseases from approved drugs to lower development costs and time, and computational prediction of protein-ligand interactions (PLI) can provide accurate and fast drug screening. The shortcomings of existing machine learning-based methods for PLI prediction include 1) using human-selected features leads to loss of information and therefore lower accuracy and 2) using limited 3D structure data for input leads to lower generalizability. Methods To address the shortcomings, I proposed DeepLPI, a novel deep learning-based model that takes as input the raw sequences of drug molecules and proteins. DeepLPI applied pre-trained embedding models to encode the raw sequences into dense vector representations, which were then fed into 1D-CNN and biLSTM to obtain predictions. BindingDB dataset was used for model training and performance evaluation that is compared with a start-of-the-art method DeepCDA. Fig 1.Principle of NLP-inspired deep learning-based methods to embed drug SMILES strings (Mol2vec) and protein sequences (ProSE). Similar drugs or proteins will be in close distance after the embedding because these methods can capture contextual information.Fig 2.Model architecture from input to output of DeepLPI. Results Results showed that the DeepLPI reached an overall AUROC of 0.79 based on the BindingDB internal test, 76% better than DeepCDA. DeepLPI also outperformed DeepCDA using the external Davis dataset (AUROC=0.53) and COVID-19 3CL Protease dataset (AUROC=0.61). Figure 3.A randomly reserved part of the BindingDB dataset was grouped into four cases for testing, according to whether the drug molecules or the proteins are seen in the training set. (Note that the drug-target pairs in the test set are excluded from the training set.)Fig 4.We compare with DeepCDA, a recently published DTI prediction model that reported to be better than previous models. DeepLPI is 76% better in accuracy metric AUROC in classification tasks.Fig 5.As a preliminary attempt, the model trained on BindingDB was applied to a recent COVID-19 dataset targeting the 3CL-protease, which reported 897 small molecule drugs. Our model is better than the baseline method by 25%. Conclusion The high performance of DeepLPI suggests that our model has the potential to identify new COVID-19 drugs when applied to approved drugs. The generalizability of the model also promises applications to diseases in a wider scope. Disclosures All Authors: No reported disclosures.

Accurate prediction of molecular properties and drug targets using a self-supervised image representation learning framework

Advanced graph and sequence neural networks for molecular property prediction and drug discovery

MaskMol: Knowledge-guided Molecular Image Pre-Training Framework for Activity Cliffs

A Molecular Video-Derived Foundation Model for Scientific Drug Discovery

MultiModal-Learning for Predicting Molecular Properties: A Framework Based on Image and Graph Structures

MaskMol: Knowledge-guided Molecular Image Pre-Training Framework for Activity Cliffs with Pixel Masking

Predicting drug-Protein interaction with deep learning framework for molecular graphs and sequences: Potential candidates against SAR-CoV-2

COVID-19 Multi-Targeted Drug Repurposing Using Few-Shot Learning

Dual-View Learning Based on Images and Sequences for Molecular Property Prediction

An effective self-supervised framework for learning expressive molecular global representations to drug discovery

Predicting drug-target binding affinity through molecule representation block based on multi-head attention and skip connection

Molecular Image-Based Convolutional Neural Network for the Prediction of ADMET Properties

Molecular persistent spectral image (Mol-PSI) representation for machine learning models in drug design

A Molecular Image-based Explainable Artificial intelligence Framework Identifies Novel Candidate Antibiotics

A deep learning framework for predicting molecular property based on multi-type features fusion

Prediction of chemical compounds properties using a deep learning model

Inductive transfer learning for molecular activity prediction: Next-Gen QSAR Models with MolPMoFiT

MOL-MOE: Learning Drug Molecular Characterization Based on Mixture of Expert Mechanism

519. DeepLPI: A Novel Drug Repurposing Model based on Ligand-Protein Interaction Using Deep Learning

Advanced deep learning methods for molecular property prediction

Pre-trained molecular representations enable antimicrobial discovery